Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIngenta Regulatory News (ING)

Share Price Information for Ingenta (ING)

Share Price is delayed by 15 minutes
Get Live Data
76.00    -8.50 (-10.06%)
Bid:
75.00
Ask:
77.00
Spread: 2.00 (2.667%)
Market Cap: £11.03m
ING Live PriceLast checked at - London Stock Exchange

Intraday Ingenta Share Chart

Trading Update and Contract W

26 Jun 2008 07:00

RNS Number : 5661X
Publishing Technology PLC
26 June 2008
 



Publishing Technology PLC ("Publishing Technology" or "the Company")

Contract win and trading update

Publishing Technology which provides targeted software and consulting solutions for publishers and information providers is pleased to announce that Washington DC based BioOne, has selected the PCG division of Publishing Technology PLC to provide its content sales representation. BioOne who provide a unique aggregation of high-impact bioscience research journals, have seen a consistently large increase in sales since its inception eight years ago, have selected PCG because they believe that PCG can provide the impetus to continue the growth.

The three year agreement will represent a 50% increase in revenues (approx £500,000 net) for the PCG division of Publishing Technology in 2009, with sales starting in quarter three of 2008.

Trading update

The Board of Publishing Technology believes that contract gains such as BioOne underline the achievements of the group since its inception in 2007. In 2008, the group has concentrated on increasing revenues whilst rationalising costs, and focusing on higher margin activities, and the Board is pleased to report positive progress on all fronts. Revenues have increased quarter on quarter and overheads reduced, whilst, with the addition of the BioOne contract, recurring revenues are now expected to exceed 65% of total revenues for the group. Cross-selling of the range of products and services within our established customer base has exceeded forecasts, and the order book for the remainder of the year is healthy with a high level of signed business. 

The Board is seeing no discernable slow down in market activity, and believes this is because Publishing Technology provides the means for publishers and information providers to increase their revenues, whilst rationalising their costs.

The Board intends to continue to pursue organic growth and increased profits and, where appropriate, earning enhancing acquisition opportunities. A further update will be given at the time of the interim results in August 2008.

George Lossius, CEO of Publishing Technology commented:

"This represents a significant advance for the PCG division which has shown significant growth in the last couple of years, and this contract will support the group as it targets growth and increased profits. BioOne is a highly respected source of bioscience research materials, and we are delighted to be given this opportunity to represent BioOne and its team. " 

Martyn Rose, Chairman commented

"I am delighted with the progress Publishing Technology has made since its inception, and feel more confident now than at any time that the merger of last year was the right thing for us, our investors and customers, and I would like to thank them for their support during this time."

For further information please contact:

Publishing Technology PLC

George Lossius/Alan Moug 01865 397800

FinnCap, nominated adviser

Geoff Nash/Rose Herbert 020 7600 1658

The Communication Group plc 

Richard Evans  020 7630 1411 / 0775 108 7291

Kit Bingham 020 7630 1411 / 0788 074 8672

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTUVVRRWORNUUR
Date   Source Headline
25th Jun 20267:00 amRNSAGM Trading Update
1st May 20267:01 amRNS-RInvestor Presentation via Investor Meet Company
1st May 20267:00 amRNSPosting of Annual Report & Notice of AGM
27th Apr 20267:00 amRNSFinal Results
22nd Jan 20267:00 amRNSTrading Update
18th Nov 20254:30 pmRNSHolding(s) in Company
18th Nov 20254:29 pmRNSHolding(s) in Company
4th Nov 20253:21 pmRNSHolding(s) in Company
7th Oct 20257:00 amRNSHolding(s) in Company
29th Sep 20255:27 pmRNSHolding(s) in Company
18th Sep 202511:00 amRNSInvestor Presentation via Investor Meet Company
15th Sep 20257:00 amRNSHalf-year Report
26th Jun 20254:42 pmRNSResult of Annual General Meeting
7th May 20254:54 pmRNSPosting of Annual Report & Notice of AGM
28th Apr 20257:00 amRNSFinal Results
7th Feb 20257:00 amRNSTrading Update
15th Nov 20244:52 pmRNSHolding(s) in Company
18th Sep 20247:00 amRNSHalf-year Report
18th Jul 20244:42 pmRNSResult of AGM and Directorate Change
3rd Jul 20247:00 amRNSTransaction in Own Shares
24th Jun 20244:30 pmRNSPosting of Annual Report & Notice of AGM
3rd Jun 20247:00 amRNSDirector/PDMR Shareholding
31st May 20247:00 amRNSInvestor Presentation via Investor Meet Company
28th May 20247:00 amRNSFinal Results
17th May 20242:20 pmRNSFinal Results Update
31st Jan 20247:00 amRNSTrading Update
25th Oct 20233:57 pmRNSChange of Nomad and Broker
17th Oct 20235:41 pmRNSHolding(s) in Company
28th Sep 20237:00 amRNSNew customer wins
11th Sep 20237:00 amRNSHalf-year Report
8th Sep 20232:44 pmRNSInvestor Presentation via Investor Meet Company
31st Jul 20237:00 amRNSTrading Update
29th Jun 202312:52 pmRNSResult of AGM & Dividend Timetable
29th Jun 20237:00 amRNSAGM statement and contract wins
25th May 20234:00 pmRNSPosting of Annual Report & Notice of AGM
17th May 20237:00 amRNSInvestor Presentation via Investor Meet Company
11th May 20237:00 amRNSFinal Results
28th Apr 20237:00 amRNSNotice of Final Results
2nd Feb 20237:00 amRNSTrading Update
2nd Dec 20226:02 pmRNSDirector/PDMR Shareholding
16th Nov 20224:31 pmRNSHolding(s) in Company
14th Nov 20223:57 pmRNSResult of Tender Offer
11th Nov 202211:24 amRNSResult of General Meeting
25th Oct 20227:00 amRNSProposed Tender Offer & Notice of General Meeting
21st Sep 20227:00 amRNSHalf-year Report
13th Sep 20227:00 amRNSNotice of Interim Results & Investor Presentation
3rd Aug 20222:09 pmRNSHolding(s) in Company
1st Aug 20227:00 amRNSTrading Update
28th Jul 20223:02 pmRNSResult of AGM and Dividend Timetable
8th Jul 20227:00 amRNSGrant of Options

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.